References
  1. World Health Organization. Coronavirus disease 2019 (COVID): situation report 77. Published April 6, 2020. Accessed April 7, 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200406-sitrep-77-covid-19.pdf?sfvrsn=21d1e632_2
  2. Fitzmaurice C, Allen C, Barber RM, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A systematic analysis for the global burden of disease study. JAMA Oncology 2017;3:524–548
  3. Aviv JE. Clinical Assessment of Pharyngolaryngeal Sensitivity.Am J Med . 2000 Mar 6;108 Suppl 4a:68S-72S.
  4. Ku PK, Vlantis AC, Leung SF, et al. Laryngopharyngeal Sensory Deficits and Impaired Pharyngeal Motor Function Predict Aspiration in Patients Irradiated for Nasopharyngeal Carcinoma. Laryngoscope. 2010 Feb;120:223-8.
  5. Tang B, Wang X, Li Q, et al. Estimation of the Transmission Risk of the 2019-nCoV and Its Implication for Public Health Interventions. J Clin Med. 2020 Feb 7;9:462.
  6. Patel ZM, Fernandez-Miranda J, Hwang PH, et al. Precautions for endoscopic transnasal skull base surgery during the COVID-19 pandemic. American Academy of otolaryngology-Head and Neck Surgery, coronavirus disease 2019: resources. Published March 23, 2020, Accessed March 27, 2020 https://www.entnet.org/sites/default/files/uploads/covid-19_endosb_lettertoeditor_neurosurgery_update3.23.20.pdf
  7. ENT UK. Loss of sense of smell as marker of COVID-19 infection. Published March 21 2020, Accessed April 6, 2020. https://www.entuk.org/sites/default/files/files/Loss%20of%20sense%20of%20smell%20as%20marker%20of%20COVID.pdf.
  8. Consensus document on the epidemiology of SARS. World Health Organization Wkly Epidemol Rec. 2003;78:373-5. Accessed April 3, 2020 https://www.who.int/csr/sars/en/WHOconsensus.pdf
  9. Lindsley WG, Pearce TA, Hudnall JB, et al. Quantity and size distribution of cough-generated aerosol particles produced by influenza patients during and after illnesses. J Occup Environ Hyg. 2012;9:443-449.
  10. Yu X, Yang R. COVID-19 Transmission Through Asymptomatic Carriers Is a Challenge to Containment. Influenza Other Respir Viruses. 2020 Apr 4. doi: 10.1111/irv.12743.
  11. ENT UK. Anosmia as a potential marker of COVID-19 infection – an update. Published April 6, 2020. Accessed April 8, 2020 https://www.entuk.org/anosmia-potential-marker-covid-19-infection-–-update
  12. Carnaby GD, Crary MA Development and validation of a cancer specific swallowing assessment tool: MASA-C. Supportive Care in Cancer . 2014;22:595-602.
  13. Cichero JA, Lam P, Steele CM, et al. Development of international terminology and definitions for texture-modified foods and thickened fluids used in dysphagia management: The IDDSI Framework.Dysphagia. 2017;32:293-314.
  14. Sharma S, Ward EC, Burns C, Theodoros D, Russell T. Assessing swallowing disorders online: a pilot telerehabilitation study.Telemedicine e-Health. 2011;17:688-95.
  15. Chen AY, Frankowski R, Bishop-Leone J, et al. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M.D. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg . 2001;127:870-6.
  16. Zhang LJ, Jiang N, Li Z, et al. Psychometric properties of the Chinese version of the M.D. Anderson Dysphagia Inventory for head and neck cancer patients. Cancer Nurs. 2017;40:E9-16.
  17. Wallace KL Middleton S, & Cook IJ. Development and validation of a self-report symptom inventory to assess the severity of oro-pharyngeal dysphagia. Gastroenterol . 2000;118:678-87.
  18. Belafsky PC, Mouadeb DA, Rees CJ, et al. Validity and reliability of the Eating Assessment Tool (EAT-10). Ann Otol Rhinol Laryngol . 2008;117:919-24.
  19. Dwivedi RC, St Rose S, Roe JW, et al. Validation of the Sydney Swallow Questionnaire (SSQ) in a cohort of head and neck cancer patients.Oral Oncol . 2010;46:e10-4.
  20. Ward EC, Conroy AL. Validity, reliability and responsivity of the Royal Bisbrane hospital outcome measure for swallowing. Asian Pacific J Speech Lang Hear 1999;4:109-129.
  21. List MA, D’Antonio LL, Cella DF, et al. The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy-head and neck scale. Cancer . 1996;77:2294-201.
  22. Crary MA, Mann GD, & Groher ME. Initial psychometric assessment of a functional oral intake scale for dysphagia in stroke patients.Arch Phys Med Rehabil. 2005;86:1516-20.
  23. Kunieda K, Ohno T, Fujishima I, Hojo K, Morita T. Reliability and Validity of a Tool to Measure the Severity of Dysphagia: The Food Intake LEVEL Scale. Pain Symptom Manage . 2013;46:201-6.
  24. Ward EC, Burns CL, Theodoros DG, Russell TG. Impact of dysphagia severity on clinical decision making via telerehabilitation.Telemed J E Health. 2014;20:296-303.
  25. Wall LR, Ward EC, Cartmill B. Adherence to a prophylactic swallowing therapy program during (chemo) radiotherapy: Impact of service delivery model and patient factors. Dysphagia. 2016;32:279-92.
  26. Starmer HM, Abrams R, Webster K, et al. Feasibility of a mobile application to enhance swallowing therapy for patients undergoing radiation-based treatment for head and neck cancer. Dysphagia . 2018;33:227-33.
  27. Constantinescu G, Kuffel K, King B, Hodgetts W, Rieger J. Usability testing of an mHealth device for swallowing therapy in head and neck cancer survivors. Health Informat J . 2018;25:1373-82